Skip to content

Medical Information for Clinicians

Citations of peer-reviewed articles from leading medical journals that present evidence in support of clinical strategies to preempt allogeneic blood transfusion in a variety of medical and surgical settings.

Contact Us

Featured Articles

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial. (opens new window)

Platzbecker U, Santini V, Fenaux P, Sekeres MA, Savona MR, Madanat YF, Díez-Campelo M, Valcárcel D, Illmer T, Jonášová A, Bělohlávková P, Sherman LJ, Berry T, Dougherty S, Shah S, Xia Q, Sun L, Wan Y, Huang F, Ikin A, Navada S, Feller F, Komrokji RS, Zeidan AM

Source‎: Lancet 2024;403(10423):249-60.

Indexed‎: PubMed 38048786

DOI‎: 10.1016/S0140-6736(23)01724-5

https://pubmed.ncbi.nlm.nih.gov/38048786/ (opens new window)

Clinical Strategies

Medicine and Surgery

Clinical strategies for managing hemorrhage and anemia without allogeneic blood transfusion.

Pediatrics

Clinical strategies for managing neonatal and pediatric patients without allogeneic blood transfusion.

Diseases and Conditions

Clinical strategies for managing specific diseases or conditions without allogeneic blood transfusion.

Bioethics and Law

Ethical, legal, and social factors for health-care professionals to consider when treating Jehovah’s Witnesses.

Contact Local Representative

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.